Recall Radar
All recallsMedicine & devices

Duloxetine Delayed-Release Capsules, USP, 30mg, 1000 Capsule bottles, Rx only, Manufactured. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Distributed by:…

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit

Class II Medicine & devices FDA June 17, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
Breckenridge Pharmaceutical, Inc. — Berkeley Heights, NJ
Severity
Class II — moderate
Reported
June 17, 2026
Quantity
14,729 bottles.
Recall number
D-0582-2026
Status
Ongoing
Source
FDA

Where it went

Nationwide within the United States

Other medicine & devices recalls

See every current recall on the live dashboard →